Cas 791850-62-9,3-Pyridinecarbonitrile, 6-[4-[[4-(2-methyl-1H-benzimidazol-1-yl)-1-piperidinyl]methyl]phenyl]-5- phenyl-

791850-62-9

Post Buying Request

Basic information

Product Name: 3-Pyridinecarbonitrile, 6-[4-[[4-(2-methyl-1H-benzimidazol-1-yl)-1-piperidinyl]methyl]phenyl]-5- phenyl-
Synonyms:
CAS NO:791850-62-9
Molecular Formula: C32H29N5
Molecular Weight: 483.616
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-Pyridinecarbonitrile, 6-[4-[[4-(2-methyl-1H-benzimidazol-1-yl)-1-piperidinyl]methyl]phenyl]-5- phenyl-(CAS DataBase Reference)
NIST Chemistry Reference: 3-Pyridinecarbonitrile, 6-[4-[[4-(2-methyl-1H-benzimidazol-1-yl)-1-piperidinyl]methyl]phenyl]-5- phenyl-(791850-62-9)
EPA Substance Registry System: 3-Pyridinecarbonitrile, 6-[4-[[4-(2-methyl-1H-benzimidazol-1-yl)-1-piperidinyl]methyl]phenyl]-5- phenyl-(791850-62-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 791850-62-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

791850-62-9 Suppliers

Recommended suppliers

791850-62-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 791850-62-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,1,8,5 and 0 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 791850-62:
(8*7)+(7*9)+(6*1)+(5*8)+(4*5)+(3*0)+(2*6)+(1*2)=199
199 % 10 = 9
So 791850-62-9 is a valid CAS Registry Number.

791850-62-9Upstream product

791850-62-9Downstream Products

791850-62-9Relevant academic research and scientific papers

Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitors

Zhao, Zhijian,Leister, William H.,Robinson, Ronald G.,Barnett, Stanley F.,Defeo-Jones, Deborah,Jones, Raymond E.,Hartman, George D.,Huff, Joel R.,Huber, Hans E.,Duggan, Mark E.,Lindsley, Craig W.

, p. 905 - 909 (2007/10/03)

This letter describes the discovery of a novel series of dual Akt1/Akt2 kinase inhibitors, based on a 2,3,5-trisubstituted pyridine scaffold. Compounds from this series, which contain a 5-tetrazolyl moiety, exhibit more potent inhibition of Akt2 than Akt1.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 791850-62-9